Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1996; Volume 276,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 352;
  • You have access
    A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    S H Graham, J Chen, J Q Lan and R P Simon
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 1-4;
  • You have access
    Novel anti-inflammatory compounds prevent CD11b/CD18, alpha M beta 2 (Mac-1)-dependent neutrophil adhesion without blocking activation-induced changes in Mac-1.
    G Endemann, Y Feng, C M Bryant, G S Hamilton, J Perumattam, R E Mewshaw and D Y Liu
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 5-12;
  • You have access
    Tachyphylaxis to angiotensin II and [Phe4]-angiotensin II in the rat mesentery in vivo.
    S P Tofovic and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 13-20;
  • You have access
    Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding.
    J Thornton-Manning, M L Appleton, F J Gonzalez and G S Yost
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 21-29;
  • You have access
    Determination of Km for oxygen of nitric oxide synthase isoforms.
    A Rengasamy and R A Johns
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 30-33;
  • You have access
    The effects of clomipramine on the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro.
    R D Trifunović and M S Brodie
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 34-40;
  • You have access
    Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    G D Bartoszyk, J Harting and K O Minck
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 41-48;
  • You have access
    Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    N Hotta, N Koh, F Sakakibara, J Nakamura, Y Hamada, T Wakao, T Hara, K Mori, K Naruse, E Nakashima and N Sakamoto
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 49-55;
  • You have access
    Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    F Rodríguez de Fonseca, P Rubio, F Menzaghi, E Merlo-Pich, J Rivier, G F Koob and M Navarro
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 56-64;
  • You have access
    Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray.
    P J Monroe, A A Hawranko, D L Smith and D J Smith
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 65-73;
  • You have access
    The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions.
    M H Chin, C L Cioffi, M Garay, R F Neale, S S Shetty, D DelGrande, B Mugrage, M A Sills and K E Lipson
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 74-83;
  • You have access
    YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    M Shimizu-Sasamata, S Kawasaki-Yatsugi, M Okada, S Sakamoto, S Yatsugi, J Togami, K Hatanaka, J Ohmori, K Koshiya, S Usuda and K Murase
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 84-92;
  • You have access
    A novel P1 purinoceptor activates an outward K+ current in follicular oocytes of Xenopus laevis.
    B F King, J Pintor, S Wang, A U Ziganshin, L E Ziganshina and G Burnstock
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 93-100;
  • You have access
    Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene.
    W Tassaneeyakul, D J Birkett, J W Edwards, M E Veronese, W Tassaneeyakul, R H Tukey and J O Miners
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 101-108;
  • You have access
    Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    J X Mazoit, L S Cao and K Samii
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 109-115;
  • You have access
    The role of 5-HT3 receptors in periaqueductal gray-induced inhibition of nociceptive dorsal horn neurons in rats.
    Y B Peng, Q Lin and W D Willis
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 116-124;
  • You have access
    Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.
    R M Edwards, W Trizna, E J Stack and J Weinstock
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 125-129;
  • You have access
    Beta adrenergic receptor activation attenuates the generation of inositol phosphates in the pregnant rat myometrium. Correlation with inhibition of Ca++ influx, a cAMP-independent mechanism.
    L D Khac, S Arnaudeau, N Lepretre, J Mironneau and S Harbon
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 130-136;
  • You have access
    Tetrahydro-9-aminoacridine has mixed actions on muscarinic currents and blocks opioid currents in rat locus ceruleus neurons.
    P B Osborne and M J Christie
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 137-142;
  • You have access
    Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells.
    C J Hough, R P Irwin, X M Gao, M A Rogawski and D M Chuang
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 143-149;
  • You have access
    ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.
    K Shiosaki, P Jenner, K E Asin, D R Britton, C W Lin, M Michaelides, L Smith, B Bianchi, S Didomenico, L Hodges, Y Hong, L Mahan, J Mikusa, T Miller, A Nikkel, M Stashko, D Witte and M Williams
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 150-160;
  • You have access
    Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    S Subramaniam, S D Donevan and M A Rogawski
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 161-168;
  • You have access
    Evidence that a nereistoxin metabolite, and not nereistoxin itself, reduces neuronal nicotinic receptors: studies in the whole chick ciliary ganglion, on isolated neurons and immunoprecipitated receptors.
    Y Xie, T McHugh, J McKay, G S Jones and R H Loring
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 169-177;
  • You have access
    Acetylcholine-induced chloride current oscillations in swine tracheal smooth muscle cells.
    X Liu and J M Farley
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 178-186;
  • You have access
    Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    M Hatch, R W Freel, S Shahinfar and N D Vaziri
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 187-193;
  • You have access
    ATP depletion by iodoacetate and cyanide in renal distal tubular cells.
    L H Lash, J J Tokarz, Z Chen, B M Pedrosi and E B Woods
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 194-205;
  • You have access
    Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    D Wu, R J Boado and W M Pardridge
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 206-211;
  • You have access
    Electrocorticographic desynchronization after application of visceral and somatic noxious stimuli in urethane-anesthetized rats: effect of intrathecal administration of tachykinin (NK 1 or NK 2) receptor antagonists.
    B Conte, C Cutrufo and S Manzini
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 212-218;
  • You have access
    Uptake of cimetidine into syncytial microvillus membrane vesicles of human term placenta.
    E M van der Aa, A C Wouterse, C E Verrijt, J H Peereboom-Stegeman and F G Russel
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 219-222;
  • You have access
    Autoradiographic evidence for the modulation of in vivo sigma receptor labeling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain.
    P Bouchard, F Roman, J L Junien and R Quirion
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 223-230;
  • You have access
    A catechol derivative (4-methylcatechol) accelerates the recovery from experimental acrylamide-induced neuropathy.
    K Saita, T Ohi, Y Hanaoka, S Furukawa, Y Furukawa, K Hayashi and S Matsukura
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 231-237;
  • You have access
    Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP.
    J S Sidhu and C J Omiecinski
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 238-245;
  • You have access
    Cationized hyperimmune immunoglobulins: pharmacokinetics, toxicity evaluation and treatment of human immunodeficiency virus-infected human-peripheral blood lymphocytes-severe combined immune deficiency mice.
    W M Pardridge, Y S Kang, A Diagne and J A Zack
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 246-252;
  • You have access
    Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms.
    L Y Chen and J L Mehta
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 253-257;
  • You have access
    Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity.
    J C Kraner, E T Morgan, T S Poet, S L Born, V L Burnett and J R Halpert
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 258-264;
  • You have access
    The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.
    G Yue, F F Sun, C Dunn, K Yin and P Y Wong
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 265-270;
  • You have access
    Long-term safety of the aminobisphosphonate alendronate in adult dogs. I. General safety and biomechanical properties of bone.
    C P Peter, J Guy, M Shea, W Bagdon, W F Kline and W C Hayes
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 271-276;
  • You have access
    Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.
    R Balena, A Markatos, J G Seedor, M Gentile, C Stark, C P Peter and G A Rodan
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 277-283;
  • You have access
    125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
    T Hussain, J Linden and S J Mustafa
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 284-288;
  • You have access
    Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    M Gopalakrishnan, L M Monteggia, D J Anderson, E J Molinari, M Piattoni-Kaplan, D Donnelly-Roberts, S P Arneric and J P Sullivan
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 289-297;
  • You have access
    Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
    J B McMahon, R W Buckheit, R J Gulakowski, M J Currens, D T Vistica, R H Shoemaker, S F Stinson, J D Russell, J P Bader, V L Narayanan, R J Schultz, W G Brouwer, E E Felauer and M R Boyd
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 298-305;
  • You have access
    Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.
    K L Widnell, D W Self, S B Lane, D S Russell, V A Vaidya, M J Miserendino, C S Rubin, R S Duman and E J Nestler
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 306-315;
  • You have access
    The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    X Tao, L S Davis, K Hashimoto and P E Lipsky
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 316-325;
  • You have access
    Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
    D J Hnatowich, G Mardirossian, M Fogarasi, T Sano, C L Smith, C R Cantor, M Rusckowski and P Winnard
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 326-334;
  • You have access
    Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes.
    G Rossoni, A Sala, F Berti, T Testa, C Buccellati, C Molta, R Muller-Peddinghaus, J Maclouf and G C Folco
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 335-341;
  • You have access
    Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.
    D G Standaert, C M Testa, G D Rudolf and Z R Hollingsworth
    Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 342-352;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 276, Issue 1
1 Jan 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics